HYDROS
Professional system for Aquablation therapy combining imaging, clinician-reviewed treatment planning and robotic waterjet resection.
For healthcare professionals. TINLAD does not sell medical devices, give clinical advice or collect patient data. Indications depend on jurisdiction and current labeling; contact the manufacturer through its official professional channel.
Independent TINLAD catalog listing based on official manufacturer sources. Not a partnership, distributor or reseller arrangement.
Manufacturer-stated specifications
Manufacturer claims, not demonstrations verified by TINLAD.
- Treatment planning
- FirstAssist AI
- Imaging
- Ultrasound · cystoscopy
Operating limits & scope
AI suggests a plan for surgeon review; it does not choose or perform treatment. AquaBeam country listings are not copied to HYDROS. No outcome guarantees.
Authorization record by jurisdiction
United States
FDA 510(k) clearance · K240200 · 2024-08-20 · Substantially equivalent
Checked in regulator database · www.accessdata.fda.gov
European Union and United Kingdom
Manufacturer-stated regional labeling / indications (no CE/MDR basis claimed)
Manufacturer statement — certificate not independently audited · www.procept-biorobotics.com
Regulatory scope
US labeling: resection and removal of prostate tissue in males with lower urinary tract symptoms due to benign prostatic hyperplasia. EU/UK labeling (manufacturer-stated regional indications): resection and removal of prostate tissue in males with lower urinary tract symptoms.
Entity type
Medical device
Physical form
Surgical system
Commercial status
Commercially offered (manufacturer)
Verified regions
Not verified — confirm with the manufacturer
Operating mode
Surgeon-controlled · Supervised deployment
Deployment, safety assessment and integration remain the responsibility of the manufacturer and integrator.
Official sources
- PROCEPT HYDROS (checked 2026-10-30)
- PROCEPT safety information (checked 2026-10-30)
- FDA 510(k) K240200 (checked 2026-10-30)